Radiation Therapy and Combination Chemotherapy for Medulloblastoma

NCT02681705 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Medulloblastoma

Interventions

DRUG: Temozolomide
RADIATION: Craniospinal Radiation

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine